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Abstract
Natural killer (NK) cells are innate cytotoxic lymphocytes that specialize in the defense against viral infection and oncogenic
transformation. Their action is tightly regulated by signals derived from inhibitory and activating receptors; the later include
proteins such as the Natural Cytotoxicity Receptors (NCRs: NKp46, NKp44 and NKp30). Among the NCRs, NKp46 is the only
receptor that has a mouse orthologue named Ncr1. NKp46/Ncr1 is also a unique marker expressed on NK and on Lymphoid
tissue inducer (LTI) cells and it was implicated in the control of various viral infections, cancer and diabetes. We have
previously shown that human NKp46 recognizes viral hemagglutinin (HA) in a sialic acid-dependent manner and that the O-
glycosylation is essential for the NKp46 binding to viral HA. Here we studied the molecular interactions between Ncr1 and
influenza viruses. We show that Ncr1 recognizes influenza virus in a sialic acid dependent manner and that N-glycosylation
is important for this binding. Surprisingly we demonstrate that none of the predicted N-glycosilated residues of Ncr1 are
essential for its binding to influenza virus and we thus conclude that other, yet unidentified N-glycosilated residues are
responsible for its recognition. We have demonstrated that N glycosylation play little role in the recognition of mouse tumor
cell lines and also showed the in-vivo importance of Ncr1 in the control of influenza virus infection by infecting C57BL/6 and
BALB/c mice knockout for Ncr1 with influenza.
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Introduction
Natural killer (NK) cells are innate cytotoxic lymphocytes that
specialize in the defense against viral infection and oncogenic
transformation [1,2,3]. Their activity is tightly regulated by
cytokines and by signals derived from inhibitory and activating
receptors [1,2,3]. Mostly MHC-I molecules, but also other
proteins inhibit the activity of NK cells by binding to multiple
NK inhibitory receptors that belong to the Ig super family and to
the C-type lectin family [1,2,3]. The NK cell cytotoxicity is also
positively controlled by activating receptors that include proteins
such as CD16, NKp80, 2B4, NKG2D and the NCRs; NKp46,
NKp44, and NKp30 [1,2,3]. Among the NCRs, NKp46 is the
only receptor that has a mouse orthologe named Ncr1 [3,4].
NKp46/Ncr1 is also a unique marker expressed on NK and on
Lymphoid tissue inducer (LTI) cells [3]. It was implicated in the
control of various viral infections [4,5,6], cancers [7,8,9], bacterial
infection such as Fusobacterium nucleatum [10] and type I diabetes
[11,12].
Although the NCRs were discovered more than a decade ago
[3], the identity of some of their ligands, particularly those
recognized by NKp46/Ncr1 (such as the self, beta cell-derived
[11,12], bacterial [10]and tumor ligands [7,8,13]), is still obscure.
Around 10 years ago we have identified viral hemagglutinin (HA)
as a ligand for NKp46 and NKp44 [6,9]. We have demonstrated
that sialic acid residues play a critical role in the binding of both
NKp44 and NKp46 to viral HA and showed that O-glycosylation
of the sialic acid carrying residue threonine (located in position 225
of NKp46) is critical for the recognition of HA and of some tumor
ligands _ENREF_1 [5]. Recently we showed that NKp46/Ncr1
interacts with a self-ligand expressed by beta cells in a sialic acid
independent manner and that the Asn 216 and Thr 125 residues
are important for beta cell recognition [12]. We further showed
that glycosylation is not required for the NKp46/Ncr1 recognition
of Fusobacterium nucleatum [10]. It is unknown how Ncr1 recognizes
tumors and influenza viruses.
The importance of the interaction of Ncr1 with influenza virus
was also confirmed in-vivo [4]. We have generated mice deficient
for Ncr1 (Ncr1gfp/gfp) by replacing parts of the Ncr1 gene with GFP
and demonstrated that these mice succumb to influenza virus
infection [4]. The critical role of Ncr1 in the recognition of
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influenza viruses was further emphasized by the recent discoveries
demonstrating that influenza viruses developed various mechan-
isms to evade the Ncr1-mediated recognition. These include
mutating the viral HA [14], infecting NK cells [15] and enhancing
the inhibitory signals mediated by MHC class I [16,17].
Furthermore, it was recently shown that both NKp46 and
NKp30 bind to poxviral HA [18] and surprisingly, while the
NKp46 recognition of poxviral HA leads to increased NK cell
cytotoxicity, the binding of NKp30 leads to inhibition of NK cell
killing via an unknown mechanism [18].
It is important to study the interactions between Ncr1 and HA
and to compare it with the NKp46 interactions with HA in order
to understand how previous and future work using mice models of
influenza virus infection would be relevant in humans. Thus, we
investigated here the mechanisms by which Ncr1 recognizes the
influenza virus. Additionally, we demonstrate an Ncr1-mediated,
dose dependent control of the PR8 influenza virus infection by
infecting two inbred mouse strains, C57BL/6 and BALB/c
knocked out for Ncr1 with influenza.
Materials and Methods
Mice, Killing Assays and in-vivo PR8 Infection
All animal work has been conducted according to relevant
national and international guidelines. In accordance with the
recommendations of the Weatherall report. The work was
approved by the Hebrew University Medical School Ethic
committee (Ethics number MD-10-12595-5). All the experiments
were performed in a specific pathogen free unit of the Hebrew
University Medical School (Ein-Kerem, Jerusalem) in accordance
with the guidelines of the ethics committee. All experiments were
performed using 6–8 weeks old female mice of the C57BL/6 or
BALB/c backgrounds. The generation of the Ncr1 knockout mice
Ncr1gfp/gfp (KO) was described previously [4]. Both C57BL/6 and
BALB/c mouse lines used were congenic lines generated from the
original KO line (129/Sv background). For the killing and
redirected killing assays, peripheral blood lymphocytes (PBLs)
were harvested 18 hours following 200 mg poly(I):poly(C) in 200 ml
PBS administered by i.p. injection to Ncr1+/+ (WT) and Ncr1gfp/
gfp (KO) mice of the C57BL/6 and BALB/c strains. The PBLs
were incubated with EL4 cells and specific killing was determined
as previously described [9]. Re-directed experiments were
performed as previously described [9], briefly: P815 cells
expressing Fc-c receptor were coated with anti Ncr1 antibody to
induce the re-directed NK cell killing for one hour on ice (to allow
the binding of the anti-Ncr1 antibody to the P815 cells via its Fc)
and NK cells were then added for additional 5 hours at 370C. For
the in-vivo PR8 infection, mice were lightly anesthetized with 2%
Isoflurane and intranasally inoculated with 4, or 40 hemaggluti-
nation units (HU) in 40 ml PBS. Mice were monitored thereafter
daily for mortality. The human PR8 virus (A/PR/8/34) was used
in all in-vivo and in-vitro experiments.
Cells and in-vitro Coating with PR8 Influenza Virus
The cell lines used in PR8 influenza coating experiments were:
The murine carcinogen induced lymphoma EL4 (ATCC), the
virus-induced murine thymic lymphoma PD1.6 [14] and the
human EBV transformed B cell lymphoma 721.221 (ATCC). The
Canine kidney epithelial cells MDCK were used for influenza
infection (ATTC). Propagation of the human influenza virus A/
Puerto Rico/8/34 H1N1 (PR8) was performed as previously
described [17]. Coating of the various cells with the virus was
performed by incubating 1*106 cells in 2 ml complete medium
with 10 ml or 20 ml (1000 HU over night at 37uC, 5% CO2.
Infection of MDCK cells was performed with 1000 HU of the PR8
virus. Other cells used in this study were the murine B16
melanoma cells (ATCC), the murine Lewis Lung carcinoma cells
D122 (ATCC), and the Mouse lymphoblast-like mastocytoma cell
line P815 [17].
Plasmids and Transfection
The putative glycosylation sites of Ncr1 were predicted by
Biassoni et al [19]. For the generation of the WT and mutated
Ncr1 fusion proteins, the sequence encoding the extracellular part
of Ncr1 was amplified by PCR using the 59 primer TAATAT
GAATTC ATG CTG CCA ACA CTC ACT GCC (including
EcoRI ) and the 39 PRIMER TAATAT AGATC T TG GGT
TGT GTG ATC CCA GA (including BGLII). These PCR-
generated fragments were cloned into an expression vector
containing a mutated Fc portion of human IgG1 (Fc mut
pIRESpuro).
Fusion Proteins, De-glycosylation, Abs, and flow
Cytometry
The NKp46-D1-Ig and Ncr1-Ig fusion proteins were generated
either in COS-7, or in HEK293T cells as previously described
[9,20]. Treatment of fusion proteins with neuraminidase (NA) was
performed as described [5]. For removing N-glycosylation
residues, 5 mg of NKp46-D1-Ig and Ncr1-Ig fusion proteins were
incubated overnight with 3 mg Protein N-glycosidase F (PNGas F),
in 50 ml PBS at 37uC. To remove O-glycosylation, 5 mg of
NKp46-D1-Ig and Ncr1-Ig fusion proteins were incubated for 2
hours in 50 ml PBS at 37uC with a cocktail of enzymes: 3 ml a2
3,6,8,9-neuraminidase, 3 ml b1, 4-galactosidase, 3 ml endo-a-N-
acetylgalactosaminidase, and 3 ml b1–2,3,4,6-N acetylglucosamni-
dase (Sigma Aldrich Israel). The staining of all cell lines by fusion
proteins was visualized using secondary PE or APC conjugated
goat anti-human mAbs. The anti-HA1 mAb H17-L2 is a kind gift
from Jonathan W. Yewdell (NIH). The anti-Ncr1 mAb was
generated by immunization of the Ncr1 KO mice with Ncr1-Ig.
Generation of Mutations in Ncr1-Ig
The single point mutations in the Ncr1 proteins N139A, N216A
N238A the double and the triple mutations were generated by
using PCR-based, site-directed mutagenesis approach as pre-
viously described [5]. All products were cloned in frame with
human IgG1 and the production of the fusion proteins was
performed as previously described [20]. All fusion proteins were
routinely tested for degradation on SDS PAGE gels, and no
degradation products were detected.
Statistical Analysis
Cytotoxicity at the different Effector to Target (E:T) ratios were
assessed using repeated measures ANOVA, and survival was
assessed using the Kaplan-Maier model and the Tarone-Ware test.
P,0.05 was considered significant for all comparisons.
Results
The Ncr1 Glycosylation is Predicted to be Different from
that of NKp46
The initial aim of the current research was to study whether the
mouse Ncr1 recognition of influenza virus is similar to that of the
human NKp46. We have previously demonstrated that human
NKp46 recognizes viral HA in a sialic acid dependent manner and
that the recognition of HA by NKp46 is dependent on O-
glycosylation of the Threonine residue located in position 225 of
Binding of Mouse NKp46 to Influenza Virus HA
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NKp46 [4,5,9]. Thus, we wondered whether the mouse
orthologue of NKp46, Ncr1 would demonstrate a similar glyco-
sylation-dependency. For that purpose we examined the structures
of both Ncr1 and NKp46. NKp46 is a member of the Ig super
family, consisting of a signal peptide region (residues 1–21), two Ig
like domains (I; 34–118, II; 129–211), which are held by disulfide
bonds (49«98, 144«190), a stalk region (211–259), a transmem-
branal domain (259–279) and an intracellular domain (280–304),
(Fig. 1A). It is predicted to include three glycosylated residues, two
O-glycosylations; on Thr 125 (this residue is located between the
two Ig domains of NKp46) and on Thr 225 (located in the stalk
region of NKp46) and one N-glycosylation residue, Asn 216, that
is found in the stalk region of NKp46 (Fig. 1A). Ncr1 is also
a member of the Ig super family. It consists of a signal peptide
region, (position 1–16), two Ig like domains (I; 34–118, II; 129–
211), which are held by disulfide bonds (49«98, 144«190), a stalk
region (211–256), a transmembranal domain (256–273) and an
intracellular domain (274–235), (Fig. 1B).
NKp46 and Ncr1 are substantially different with regard to their
predicted glycosylation patterns as Ncr1 is not predicted to have
O-glycosylated residues and is instead predicted to have three N-
glycosilated residues ([19] and Fig. 1B). These include: Asn 139 in
the membrane proximal Ig domain and two Asn residues located
in positions 216 and 238 in the stalk region ([19], Fig. 1B).
Because we demonstrated that the O-glycosylated residue of
NKp46 is critical for its HA recognition [4,5,9], the absence of O
glycosylation in Ncr1 suggests that the Ncr1 recognition of the
viral HA is probably different from that of NKp46.
The Ncr1-Ig Binding to PR8-coated Cells is Sialic Acid, N-
glycosylation-dependent
In light of the differences observed in the predicted glycosylation
patterns of NKp46 and Ncr1 (Fig. 1), we initially investigated
whether the Ncr1 recognition of influenza virus would also be
sialic acid dependent. To test this we used the murine carcinogen
induced lymphoma EL4 and murine virus-induced thymic
lymphoma PD1.6 cells and incubated them with the PR8
influenza virus strain. In this experimental system, the cells do
not get infected by the virus, as the coated cells do not undergo
spontaneous apoptosis and supernatant taken from the coated cells
does not infect MDCK cells (data not shown). Rather, the virus
adheres to the cells and this can be detected by the recognition of
the virus-coated cells by anti-HA mAb, as soon as one hour after
the coating (data not shown). In agreement with previous reports
[5,9], increased binding of Ncr1-Ig was observed to both virus-
coated cell lines (Fig. 2). The binding of other fusion proteins such
as CD16-Ig, KIR2DL1-Ig, KIR2DL2-Ig, NKp30-Ig, NKG2D-Ig
and LIR1-Ig was not increased (data not shown and [6,9]).
Because the increased binding of Ncr1-Ig was reduced following
the treatment of the fusion proteins with Neuraminidase (NA)
(Fig. 2), we concluded that the Ncr1 recognition of infected cells is
sialic acid dependent.
We next investigated whether the predicted N-glycosylated
residues of Ncr1 are involved in its interaction with influenza virus.
To test this, we treated the Ncr1-Ig with specific enzymes that
hydrolyze either the N-or O-glycosidic linkages. For N-de-
glycosylation we used the Protein N-glycosidase F (PNGase F),
and for O-de-glycosylation we used a cocktail of four different
enzymes (see materials and methods) that were reported to
perform exclusive cleavage of O-linked glycans [18]. The various
Ncr1-Ig fusion proteins were incubated with PR8-coated 721.221
cells that were used because the 721.221 cells do not express tumor
ligands for Ncr1 (Fig. 3A) and because the adherence of the virus
and the consequent Ncr1-Ig recognition is efficient in this cell line.
In agreement with the above results (Fig. 2), Ncr1-Ig binding was
observed to 721.221 cells coated with influenza virus (Fig. 3B) and
the increased binding was significantly reduced when the cells
were treated with NA (Fig. 3C). Importantly, treatment with N-
glycanase (PNGAse F) abolished the Ncr1-Ig binding (Fig. 3D),
whereas O-glycanase treatment had only a minimal effect (Fig. 3E).
These results indicate that similarly to NKp46, Ncr1 interacts with
the influenza virus in a sialic acid dependent manner, but contrary
to the NKp46 recognition, the Ncr1 binding of HA is N-
glycosylation dependent.
The Three Glycosylated Residues of Ncr1 are Not
Essential for its Influenza Recognition
Our next goal was to determine the identity of the specific N-
linked glycan residues that are important for HA recognition. For
this end we introduced three point mutations in the three Asn
residues located in positions 139, 216 and 238 of Ncr1, converting
them into Ala. In addition we have generated double (139 216,
216 238, 139 238) and triple mutations (139, 216, 238). We then
cloned the mutated Ncr1 genes in frame with human IgG1 and
stably transfected them into HEK293T cells. The various fusion
proteins were purified on a protein-G column and as can be seen
in figure 4A, the purity of all fusion proteins was very high.
Furthermore, all the mutated proteins had different electropho-
retic mobility, as compared to the wild type Ncr1 protein,
suggesting that the predicted residues are indeed glycosylated and
that mutating these residues had impaired their glycosylation
patterns (Fig. 4A). Similar differences were observed when Ncr1-Ig
Figure 1. Human NKp46 and mouse Ncr1 structure. The figure
shows a schematic description of the human NKp46 (A) and mouse
Ncr1 (B) domains and glycosylation positions. White circle: N-linked
glycosylation; Grey circle: O-linked glycosylation.
doi:10.1371/journal.pone.0036837.g001
Binding of Mouse NKp46 to Influenza Virus HA
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36837
was produced in COS-7 cells (data not shown), suggesting that the
glycosylation pattern of Ncr1 is not substantially different when
produced in 293T or in COS-7 cells. Interestingly, the single Ncr1
glycosylation mutants presented a double protein band in the
SDS-PAGE gels. This might be because sometimes the abolish-
ment of one glycosylation site can lead to glycosylation changes in
other sugar-carrying residues. In contrast, a single protein band
was observed in the double and the triple mutated Ncr1 proteins
(Fig. 4A), further suggesting that indeed the single mutations led to
the aberrant glycosilation of the other residues.
Next, we tested the binding of the mutated and the wild type
Ncr1 fusion proteins to 721.221 cells coated with PR8 influenza
virus and to MDCK cells infected with PR8 influenza virus (Fig. 4B
and Fig. 4C, respectively). Variations were observed in the binding
of the various fusion proteins to the infected and to the coated cells
(data not shown) and initially it seemed to us that the mutation in
each of the predicted N-glycosylated residues of Ncr1 affected its
binding. Interestingly however, consistent binding of the double
and triple mutated Ncr1 was observed to the coated (Fig. 4B) and
to the infected (Fig. 4C) cells, suggesting that none of the N-
glycosylated residues of Ncr1 play an essential role in its binding to
influenza. Notably, treatment of the wild type Ncr1 fusion protein
with NA completely abolished its binding to infected MDCK cells
and the NA treatment of the triple mutated Ncr1 fusion protein
also reduced its binding significantly but not entirely (Fig. 4D).
This suggests that other, yet unidentified glycosylated residues of
Ncr1are involved in its influenza virus recognition.
Binding of Ncr1-Ig to Tumor Cells is Primarily
Glycosylation Independent
We have previously shown that glycosylation of NKp46 is
important for its binding to some human tumor cell lines [5]. We
therefore next tested whether N glycosylation is important for the
binding of Ncr1 to mouse tumor cells. The binding of the wild type
Ncr1 fusion proteins produced either in COS-7 cells, or in
Figure 2. The increased binding of Ncr1-Ig to PR8-coated EL4
and PD1.6 cells is NA-sensitive. The figure shows FACS staining of
uncoated (left), PR8 coated 10 ml, 1000 HU (center) and 20 ml, 1000 HU
(right) EL4 (A) and PD1.6 (B). The various cells, untreated, (upper
histograms), or NA treated (lower histograms) were stained with Ncr1-Ig
(black line), and with a control fusion protein NKp46-D1-Ig (gray filled
histograms) Fluorescent intensity (MFI) is presented as the ratio
staining/background and is indicated on the upper right side of each
histogram. The figure is representative of three independent experi-
ments.
doi:10.1371/journal.pone.0036837.g002
Figure 3. N-glycosylation is required for Ncr1-Ig binding to
PR8-coated cells. The figure shows FACS staining of uncoated (A) and
PR8 coated (20 ml,1000 HU, B-E) 721.221 cells. Staining was performed
with Ncr1-Ig (black line), and a control fusion protein NKp46-D1-Ig (gray
filled histograms). Coated cells were stained with Ncr1-Ig that
underwent various treatments; untreated (B), treated with NA (C),
treated with Protein Glycosidase F (PNGase F) (D), treated with a cocktail
of O-deglycosylating enzymes (see materials and methods) (E).
Fluorescent intensity (MFI) is presented as the ratio staining/back-
ground and is indicated on the upper right side of each histogram. The
figure is representative of three independent experiments.
doi:10.1371/journal.pone.0036837.g003
Binding of Mouse NKp46 to Influenza Virus HA
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HEK293T to the various cell lines was heterogeneous, probably
reflecting the different levels of the unknown Ncr1 tumor ligand(s)
on the various cell lines (Fig. 5A). Importantly, little or no change
was observed in the binding of the single mutated fusion proteins
to the various cells lines. Specifically, while the binding of the
single mutated Ncr1 fusion proteins to B16 and D122 did not
change, decreased binding of the single mutated Ncr1 fusion
proteins to PD1.6 cells was observed (Fig. 5A). Interestingly,
however, the binding of the double and triple mutated Ncr1 fusion
proteins to all the cell lines was unchanged or even increased,
suggesting that the 3 N-glycosylated residues of Ncr1 play little
role in the recognition of the tested tumor cell lines. Indeed,
treatment of the WT Ncr1 and the triple mutated Ncr1 fusion
proteins with NA also had minimal effect on their binding (Fig. 5B)
and in all cases the NA treatment did not completely abolish the
Ncr1 binding (Fig. 5B).
Ncr1 is Essential for Influenza Virus Killing in-vitro and in-
vivo
We have previously shown by using two mouse strains (C57BL/
6 and 129/Sv) that in the absence of Ncr1 influenza virus infection
is lethal [4]. To test whether Ncr1 would be important for
influenza virus recognition in an environment dominated by Th2
cytokines, we crossed the C57BL/6 Ncr1gfp/gfp (KO) mice that we
Figure 4. The 3 N-glycosylated residues of Ncr1 are not essential for its interaction with influenza virus. (A), SDS-PAGE analysis of the
various fusion proteins. First gel (left) featuring from left to right: Ladder, WT Ncr1-Ig fusion protein and Ncr1-Ig with single point mutations, as
indicated. Second gel (right) featuring from left to right: Ladder, Ncr1-Ig with double and triple point mutations, as indicated (B), FACS staining of
uncoated (left lane) and PR8 coated (20 ml, 1000 HU, right lane) 721.221 cells. Staining was performed with a control fusion protein NKp46-D1-Ig (gray
filled histograms) with WT Ncr1-Ig generated in COS-7 cells (upper lane), and with Ncr1-Ig generated in HEK293T cells and mutated, as indicated
(lower lanes). The figure is representative of three independent stainings. (C), FACS staining of uninfected (left lane) and PR8 infected (1000 HU, right
lane) MDCK cells. Staining was performed with a control fusion protein NKp46-D1-Ig (gray filled histograms), with WT Ncr1-Ig generated in COS-7 cells
(upper lane), and with Ncr1-Ig generated in HEK293T cells and mutated, as indicated (lower lanes). The figure is representative of three independent
staining. (D) FACS staining of uninfected (filled grey histogram) PR8 infected (black line) or following NA treatment of the fusion proteins (red line)
MDCK cells with WT Ncr1-Ig (left) and triple mutated Ncr1-Ig (right). Fluorescent intensity (MFI) of each staining is presented at the top of each
histogram. The figure is representative of two independent experiments.
doi:10.1371/journal.pone.0036837.g004
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have generated [4] with BALB/c mice for more than 10
generations. Since we knocked out Ncr1 by replacing it with
GFP, all the NK cells in the Ncr1 KO and in the heterozygous
(Het) mice are GFP positive. Indeed, as can be seen in figure 6A,
which shows staining of the KO and Het mice of the C57BL/6
and BALB/c strains, all NK cells in the Het mice express GFP and
are Ncr1 positive, while the KO NK cells are GFP positive, Ncr1
negative. We further verified that Ncr1 is not functional in the
C57BL/6 and BALB/c strains by using a redirected killing assay
(see Materials and Methods section). P815 cells were pre-
incubated with anti-Ncr1 mAb and then incubated with PBLs
taken from the different mice. Figure 6B shows that the activation
Figure 5. N-glycosylation plays little role in tumor cell recognition. (A) FACS staining of various tumor cell lines (indicated above the
histograms) with control fusion protein NKp46-D1-Ig (gray filled histograms) and with Ncr1-Ig (black line) generated in COS-7 cells (upper lane),
generated in HEK293T cells (second lane up) and generated in HEK293T cells and mutated at the indicated positions (lower lanes). (B) FACS staining
of various tumor cell lines (indicated above the histograms) with control fusion protein NKp46-D1-Ig (gray filled histograms) with WT (upper and third
rows) and triple mutated (second and bottom rows) Ncr-Ig fusion proteins (black line) untreated (two upper rows) or treated with NA (two lower
rows).
doi:10.1371/journal.pone.0036837.g005
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of Ncr1 by the specific antibody resulted in the re-directed killing
of P815 cells by WT PBLs derived from C57BL/6 and BALB/c
mice, while the killing of P815 cells was much reduced when PBLs
were taken from the KO mice of either background. The little
killing of P815 cells observed with the KO PBLs is probably
mediated by NK killer receptors other than Ncr1.
To test whether NK cells of WT and KO mice of the C57BL/6
or BALB/c strains would efficiently kill murine cell lines coated
with influenza virus in-vitro, we performed direct 35S-methionine
cytotoxicity assays. Untreated and PR8 coated and 35S-methio-
nine labeled EL4 cells were incubated with PBLs derived from
WT and KO mice of the C57BL/6 and BALB/c backgrounds. As
mentioned above, the EL4 cells were not infected with influenza as
they did not undergo spontaneous apoptosis following incubation
with the virus and supernatants taken from the EL4 cells coated
with influenza were unable to infect MDCK cells (data not shown).
As can be seen in figure 6C, NK cells of both strains killed the
virus-coated cells to a significantly higher extent (coated, uncoated;
P,0.05 in both strains), and in both strains the killing was partially
Ncr1 mediated, as NK cells derived from the WT mice killed the
coated target cells significantly better than NK cells derived from
the KO mice (WT, KO; P,0.05 in both strains).
We have shown that the killing of PR8 coated cells is Ncr1-
dependent and that influenza virus infection is lethal in C57BL/6
or 129/Sv mice [4]. To test whether Ncr1 is also important for
influenza virus killing in-vivo, in the Th2 oriented BALB/c
background [21], we intranasaly infected KO and WT C57BL/
6 and BALB/c mice with three doses of PR8 influenza virus, and
monitored mortality. In the C57BL/6 mice, at the low dose of
influenza virus infection (4HU) no mortality incidence was
observed (100% survival). However, in accordance with our
previous report [4], in the higher dose of influenza virus infection
(40 HU), differences between the WT and KO mice were clearly
evident and while no mortality was observed in the WT mice,
100% of the KO mice succumbed to the infection and died
(P,0.005) (Fig. 7A).
Notably, influenza virus infection in BALB/c mice was different
than in the C57BL/6 mice. The BALB/c mice seemed to be more
sensitive to the infection as even at the low dose of influenza virus
(4 HU), nearly all the KO mice succumbed to the infection, as
evident by weight loss (data not shown) and mortality (Fig. 7B) and
even a small percent of the WT mice died. Still, however, in this
dose, a significant difference was evident between the WT and KO
mice in resistance to influenza virus infection (P,0.05). In-
terestingly, at the higher dose of influenza virus infection (40HU),
all BALB/c mice were infected, and mortality was equally high in
the WT and KO mice (Fig. 7B).
To better compare the Ncr1-dependency of the C57BL/6 and
the BALB/c mice we used the LD50 400 HU to infect the mice
(Fig. 7A and Fig. 7B). In both strains almost all the KO mice had
died, although the differences were not statistically significant.
Interestingly, in the BALB/c strain, mortality of the WT mice was
higher when less HU were administered, as mortality was near
100% at 40 HU, but reached only 60% at 400 HU (please
compare infection of BALB/c mice with 40HU versus 400 HU in
figure 7B). This difference (that was not statistically significant)
might be due to the generation of virus complexes at high HU
which reduces the efficiency of the infection.
Figure 6. Ncr1 mediated killing. (A) FACS staining of PBLs with Ncr1 mAb. The figure shows the intrinsic GFP expression of the NK cells and is
representative of two independent staining. (B) Line chart depicting 35S methionine Re-directed killing assay. Labeled p815 cells were pre-incubated
with anti-Ncr1 mAb and then incubated with PBLs harvested 18 hours following 200 mg poly(I):poly(C) in 200 ml PBS administered by i.p. injection to
WT and KO mice of the C57BL/6 and BALB/c strains. Values are shown as mean 6SEM. The figure is representative of two independent experiments.
***; P,0.0005, **; P,0.005 (C) line chart depicting 35S methionine killing assay. PBLs were harvested 18 hours following 200 mg poly(I):poly(C) in
200 ml PBS administered by i.p. injection to WT and KO mice of the C57BL/6 and BALB/c strains and incubated with labeled EL4 cells. At least 8 mice
were used in each group; a representative of three independent experiments is shown. Values are shown as mean 6SEM P,0.05.
doi:10.1371/journal.pone.0036837.g006
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Discussion
Influenza virus infection poses one of the major threats to
modern society [22]. Several major pandemics occurred in the last
two centuries; the 1918 Spanish pandemic (A/H1N1), the 1956
Asian flu (H2N2), the 1968 Hong Kong flu (H3N2) and the 2009
Swine flu (H1N1-2009) [23]. Therefore, studying influenza virus
and its interactions with the immune system is of extreme
importance. With this regard, it is also imperative that we
understand whether the interaction of the mouse immune system
with influenza virus is similar to the humans’ and whether the
experiments performed in mice are relevant for human infection.
NK cells are proficient in the eradication of a variety of virus-
infected and tumor cells [1,2,3]. Their ability to kill hazardous cells
stems, in many cases, from the activation of their killer receptors
[1,2,3]. We have shown that the interaction between NKp46/
Ncr1 and viral HA is essential for the control of influenza virus
infection in-vitro and in-vivo, and have demonstrated that sialic acid
residues are important for the binding of NKp46 [4,5,9].
Sialic acids are usually added to N- or O-linked glycans by
sialyltransferases, in either an a2–3linkage or an a2–6 linkage. O-
linked glycans that are acquired in the Golgi, on serine or
threonine residues, are less abundant than N-linked glycosylations.
O-linked glycans have a role in the binding of glycoproteins and in
the masking of the protein backbone [24].
N-linked glycans are attached to asparagine nitrogen groups
and are composed of N-acetyl galactosamine, galactose, neur-
aminic acid, N-acetylglucosamine, fructose, mannose, fucose, or
other monosaccharides assembled in
the cytoplasm and endoplasmic reticulum [24]. It was recently
reported that N-glycans are crucial in influenza virus infection and
entry into the host cells, irrespective of O linked glycans, or sialic
acids contents [25].
We have shown that the binding of NKp46 to the influenza
virus HA is sialic acid and O-glycosylation dependent [5,6,9]. In
this study, we demonstrate that the Ncr1 recognition of influenza
virus is also sialic acid mediated and that it is N-glycosylation
dependent. Surprisingly, none of the predicted N-glycosylated
residues of Ncr1 were shown to be essential for this binding.
We demonstrated that treatment of the triple mutated Ncr1
protein with NA reduced its binding to the infected cells and that
N-glycanase treatment completely abolished the binding of Ncr1
to the virus-infected/coated cells. These findings suggest that
other, yet unidentified N-glycosilation residues of Ncr1 are
important for its binding to the influenza virus. The identity of
these residues is currently unknown. An initial bioinformatics
search revealed that 3 potential N glycosylated residues are located
at the membrane distal domain of Ncr1. Future research (which is
beyond the scope of this manuscript) will determine whether these
residues are indeed glycosylated and whether they are essential for
the Ncr1 recognition of infected cells.
We suggest that the NA treatment did not completely abolish
the triple Ncr1 mutant binding to infected cells probably because
the removal of the sugars allowed a tighter binding of the fusion
proteins to the negatively charged membrane. This is also
consistent with the unchanged or increased binding of the double
and triple mutated fusion proteins that is observed to the tumor
cells. Alternatively, it is possible that other elements, which are
exposed following the removal of the sugars in the mutated Ncr1-
Ig protein are responsible for the better binding of the double and
triple mutated Ncr1 proteins to PR8 coated and infected cells and
to some tumor cells. Supporting the later option are the
observations that although almost all proteins carry sialic acids,
the recognition of influenza by Ncr1 and NKp46 seems to have
a certain unique specificity, as other glycosylated cell receptors
such as KIR2DL1, KIR2DL2, NKp30, CD16, NKG2D and
LIR1([6,9] and data not shown) do not demonstrate increased
binding to the infected cells.
HA is used by the virus to bind host cell proteins [23]. In some
of the experimental systems we used here the cells were not
infected by the virus but rather the virus only adhered to the cells.
Nevertheless, NK cells were able to kill these virus-coated cells.
This suggests that NK cells are capable of killing cells as soon as
they are contacted by the influenza virus, even before they are
actually infected. Such early killing would be very effective in
preventing infection.
Human viruses recognize N-acetyl sialic acids linked to
galactose with an a2,6 linkage in the upper respiratory tract, such
as 69SLN, and 69SLN-LN, whereas avian viruses recognize
receptors containing N-acetyl sialic acids linked to galactose by
an a2,3 linkage such as 39SLN-LN and 39SLN-LN-LN [26]. The
sialic acid binding domain of the HA protein is therefore essential
for the infectivity and virulence of the virus [27]. Indeed, although
Figure 7. Ncr1 is critical for in-vivo influenza eradication. C57BL/
6 (A) and BALB/c (B) WT and KO mice were infected with two doses of
PR8 influenza, as indicated. Survival was assessed using the Kaplan
Meier model and the Tarone-Ware test. Termination point of the
experiment was set to 20 days and mice that survived the infection
were then considered healthy. The figure represents one of two
independent experiments; at least 7 mice were used in each group.
*P,0.05, **P,0.005.
doi:10.1371/journal.pone.0036837.g007
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the HA protein undergoes extensive variations, the sialic acid
binding capacity of the HA is conserved [27,28]. This property, as
we show here and previously [4,5,9], is elegantly used by the
NKp46/Ncr1 to kill the infected cells via the sialic acid-dependent
mechanism, thus enabling NK cells to kill many different influenza
virus strains.
Viral HA is not the only ligand of the NKp46/Ncr1, as we have
previously shown [8,10,11,13]. Similar pleura of ligands is
observed with regard to other NK cell receptors such as NKG2D,
which recognizes eight different ligands (MICA, MICB and ULBP
1–6 [29]), and NKp30 which recognizes the pp65 protein of
HCMV [30], BAT3 [31], B7-H6 [32], and another unknown
ligand expressed by DCs [33]. This model of a single receptor that
recognizes several ligands enables the innate immune system to
control a wide range of pathogens and diseases.
In our previous work, we have demonstrated the importance of
Ncr1 in the control of influenza virus in-vivo, by comparing WT
and Ncr1 KO lines in two inbred mouse strains, the 129/Sv [4] (in
which signaling via the Ly49-activating receptor is impaired [34]),
and the immune-competent C57BL/6 strain. Here we tested
whether Ncr1 would be important for influenza virus eradication
in a BALB/c mouse that has a Th2 oriented immune environment
[21]. Interestingly, the function of Ncr1 in the BALB/c
background seems to be less important with regard to influenza
virus infection and these mice were indeed more sensitive to the
infection. Similar differences were observed also with regard to
other receptors and other viruses such as NKG2D and MCMV
[35,36]. The difference in sensitivity of the two mice strains to
influenza virus infection is probably due to the innate resistance of
the C57BL/6 strain to intracellular pathogens, associated with
increased activity of Th1 cells, the induction of Th1 oriented
responses and the activation of cell mediated immunity [37,38].
Conversely, BALB/c mice are more susceptible to intracellular
pathogens, as their primary response is an anti-inflammatory Th2
type, which is aimed against extracellular pathogens and involves
humoral immunity [38,39].
Finally it was recently shown that the impaired cell surface
expression of Ncr1 in a mouse named Noe´ caused a receptor-
independent, hyper reactive phenotype [40]. Some of these
findings were also reproduced in a mouse in which the iCre gene
was inserted in the 39 UTR of Ncr1, resulting in reduced mRNA
levels of Ncr1 and impaired surface expression [40]. In contrast,
the Ncr1gfp/gfp KO mice that we have generated do not show this
hyper-reactivity [4] and we and others have shown that only their
Ncr1-mediated activities are impaired [4,7,8,10,11,12,13].
The various Ncr1 mice are substantially different. Firstly, the
Ncr1gfp/gfp, Noe´ and Ncr1 iCre mice differ in the intracellular
levels of Ncr1. The Ncr1gfp/gfp has no intracellular Ncr1
expression while the Noe´ mouse was reported to have intracellular
expression of the full length Ncr1 protein [40]. The Ncr1 iCre
mouse was reported to have reduced levels of the Ncr1 transcript,
but no cell surface expression, suggesting that in this mouse the full
length Ncr1 protein is found inside the cell as well. Thus, we
propose a possibility in which the cytoplasmatic arrest of the full
length Ncr1 protein determines whether the NK cells will be hyper-
reactive (Noe´ and Ncr1 iCre) or will have impaired Ncr1-mediated
activities (Ncr1gfp/gfp).
The other major difference between the Ncr1gfp/gfp, the Noe´
and the Ncr1 iCre mice is the presence (Noe´ and Ncr1 iCre), or the
absence (Ncr1gfp/gfp) of a full length Ncr1 gene. We have knocked
out Ncr1 by replacing exons five-seven with GFP [4]. In contrast,
the complete Ncr1 gene is present in both the Noe´ (as only a single
mutation was introduced) and in the Ncr1 iCre mice (as the iCre
gene was inserted in the 39 UTR of Ncr1 [40]). Therefore, it is
possible that the missing part of the Ncr1 gene in the Ncr1gfp/gfp
mice contains certain regulatory elements that are involved in the
regulation of the NK function under certain conditions and this is
the cause for the differences observed between the various mice.
Regardless of the reasons accounting for the different phenotypes
observed in the various Ncr1 KO mice, it is clear that the Ncr1gfp/
gfp are best suitable for studying the outcome of specific functions
of Ncr1.
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